379 related articles for article (PubMed ID: 33977106)
1. Expression Pattern and Prognostic Value of EPHA/EFNA in Breast Cancer by Bioinformatics Analysis: Revealing Its Importance in Chemotherapy.
Liang Z; Wang X; Dong K; Li X; Qin C; Zhou H
Biomed Res Int; 2021; 2021():5575704. PubMed ID: 33977106
[TBL] [Abstract][Full Text] [Related]
2. The Pan-Cancer Crosstalk Between the
Xie R; Yuan M; Jiang Y
Front Cell Dev Biol; 2022; 10():790947. PubMed ID: 35309935
[No Abstract] [Full Text] [Related]
3. The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.
Wu Y; Du Z; Mou J; Qiu X; Chen J; Cai S; Ren D; Xiao F; Zhou G; Yuan C
Curr Med Chem; 2023; 30(20):2340-2353. PubMed ID: 35996244
[TBL] [Abstract][Full Text] [Related]
4. The Expression Profile and Prognostic Values of EPHA Family Members in Breast Cancer.
Zhang X
Front Oncol; 2021; 11():619949. PubMed ID: 34221956
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive prognostic and immunological analysis of ephrin family genes in hepatocellular carcinoma.
Huang S; Dong C; Zhang J; Fu S; Lv Y; Wu J
Front Mol Biosci; 2022; 9():943384. PubMed ID: 36052169
[No Abstract] [Full Text] [Related]
6. Stem-like Cells from Invasive Breast Carcinoma Cell Line MDA-MB-231 Express a Distinct Set of Eph Receptors and Ephrin Ligands.
Lucero M; Thind J; Sandoval J; Senaati S; Jimenez B; Kandpal RP
Cancer Genomics Proteomics; 2020; 17(6):729-738. PubMed ID: 33099474
[TBL] [Abstract][Full Text] [Related]
7. EPH/ephrin profile and EPHB2 expression predicts patient survival in breast cancer.
Husa AM; Magić Ž; Larsson M; Fornander T; Pérez-Tenorio G
Oncotarget; 2016 Apr; 7(16):21362-80. PubMed ID: 26870995
[TBL] [Abstract][Full Text] [Related]
8. The Value of EphB2 Receptor and Cognate Ephrin Ligands in Prognostic and Predictive Assessments of Human Breast Cancer.
Ebrahim AS; Hailat Z; Bandyopadhyay S; Neill D; Kandouz M
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360867
[TBL] [Abstract][Full Text] [Related]
9. Expression of ephrin-A ligands and EphA receptors in the developing mouse tooth and its supporting tissues.
Luukko K; Løes S; Kvinnsland IH; Kettunen P
Cell Tissue Res; 2005 Jan; 319(1):143-52. PubMed ID: 15517401
[TBL] [Abstract][Full Text] [Related]
10. Expression profiling of the ephrin (EFN) and Eph receptor (EPH) family of genes in atherosclerosis-related human cells.
Sakamoto A; Sugamoto Y; Tokunaga Y; Yoshimuta T; Hayashi K; Konno T; Kawashiri MA; Takeda Y; Yamagishi M
J Int Med Res; 2011; 39(2):522-7. PubMed ID: 21672356
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
Zhang M; Chen H; Wang M; Bai F; Wu K
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043519
[TBL] [Abstract][Full Text] [Related]
12. EphA receptors and ephrin-A ligands are upregulated by monocytic differentiation/maturation and promote cell adhesion and protrusion formation in HL60 monocytes.
Mukai M; Suruga N; Saeki N; Ogawa K
BMC Cell Biol; 2017 Aug; 18(1):28. PubMed ID: 28851287
[TBL] [Abstract][Full Text] [Related]
13. EphA family gene expression in the developing mouse neocortex: regional patterns reveal intrinsic programs and extrinsic influence.
Yun ME; Johnson RR; Antic A; Donoghue MJ
J Comp Neurol; 2003 Feb; 456(3):203-16. PubMed ID: 12528186
[TBL] [Abstract][Full Text] [Related]
14. Comparative integromics on Eph family.
Katoh M; Katoh M
Int J Oncol; 2006 May; 28(5):1243-7. PubMed ID: 16596241
[TBL] [Abstract][Full Text] [Related]
15. Viewing the Eph receptors with a focus on breast cancer heterogeneity.
Nikas I; Ryu HS; Theocharis S
Cancer Lett; 2018 Oct; 434():160-171. PubMed ID: 30055288
[TBL] [Abstract][Full Text] [Related]
16. EPHA2, EPHA4, and EPHA7 Expression in Triple-Negative Breast Cancer.
Nikas I; Giaginis C; Petrouska K; Alexandrou P; Michail A; Sarantis P; Tsourouflis G; Danas E; Pergaris A; Politis PK; Nakopoulou L; Theocharis S
Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204461
[TBL] [Abstract][Full Text] [Related]
17. Expression profile of Eph receptors and ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancer.
Hafner C; Becker B; Landthaler M; Vogt T
Mod Pathol; 2006 Oct; 19(10):1369-77. PubMed ID: 16862074
[TBL] [Abstract][Full Text] [Related]
18. Expression Profile and Prognostic Values of Mini-Chromosome Maintenance Families (MCMs) in Breast Cancer.
Cheng L; Tan Z; Huang Z; Pan Y; Zhang W; Wang J
Med Sci Monit; 2020 Aug; 26():e923673. PubMed ID: 32830194
[TBL] [Abstract][Full Text] [Related]
19. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
Carey LA; Dees EC; Sawyer L; Gatti L; Moore DT; Collichio F; Ollila DW; Sartor CI; Graham ML; Perou CM
Clin Cancer Res; 2007 Apr; 13(8):2329-34. PubMed ID: 17438091
[TBL] [Abstract][Full Text] [Related]
20. Artesunate-induced Cellular Effects Are Mediated by Specific EPH Receptors and Ephrin Ligands in Breast Carcinoma Cells.
Zadeh T; Lucero M; Kandpal RP
Cancer Genomics Proteomics; 2022; 19(1):19-26. PubMed ID: 34949656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]